Mizuho Securities analyst Salim Syed maintained a Buy rating on Vaxcyte today and set a price target of $163.00. Syed covers the Healthcare sector,......

Chevron Corporation ($CVX) has lagged the broader market so far in 2025—gaining almost 8% year-to-date compared with ~15% for the S&P 500. Yet this......

Everything to Know about Macro and Markets Last week, stocks finished with a mixed performance as investors weighed fresh inflation data and renewe......

There’s a lot to be optimistic about in the Energy sector as 2 analysts just weighed in on Chevron (CVX – Research Report) and Chord Energy (CHRD –......

In a report released today, Stephen Richardson from Evercore ISI maintained a Buy rating on Chevron, with a price target of $180.00. Richardson cov......

In a report released today, from Jefferies maintained a Buy rating on Chevron, with a price target of $179.00. In addition to Jefferies, Chevron al......

In a report released today, Ryan Todd from Piper Sandler maintained a Buy rating on Chevron, with a price target of $168.00. According to TipRanks,......

If consistent dividend payments are important to you, it’s worth paying attention to dividend aristocrats. What are Dividend Aristocrats? Dividend ......

Earnings reports, economic data, deals, and more make up the top stock market stories on Wednesday. ...

In a report released today, Betty Jiang from Barclays maintained a Hold rating on Chevron, with a price target of $158.00. Jiang covers the Energy ......